Connect with us

BUSINESS

Amyris Inc (NASDAQ: AMRS) Partners with Naomi Watts to Develop Science-Backed Wellness Care Products for Menopause

Published

on

Amyris Inc (NASDAQ: AMRS) is a top synthetic biotech corporation that operates in the wellness, beauty, and clean health industry via a leading supplier of natural and sustainable ingredients and consumer brands. The company recently announced that it would partner with Naomi Watts to develop and manufacture science-backed wellness personal care products for menopause. Ms. Naomi Watts, a mom, actress, and ONDA Beauty’s co-founder, is personally committed and dedicated to destigmatizing menopause and promoting wellness and clean skincare.

By 2025, it’s expected they’ll be about 1 billion people going through menopause worldwide. This will represent 12% of the eight billion people living on planet earth. Various symptoms and conditions are experienced by roughly 75% of all females. These can lead to the overall loss of productivity, increased need and reliance for medical resources, and reduced quality of life. Minimal product offerings at reasonable prices, lack of open forums for discussion, and stigma contribute to significant care barriers for females.

The company’s Laboratory-to-Market science and tech positions Amyris well to take control of the menopause market by producing sustainable and safe components for consumer goods with proven advantages that can help treat menopause-based complications.

Senior Management

Ms. Watts said that the lack and shame of a community that surrounds the menopause topic have made her feel alone, overwhelmed and confused. The fact that people believe menopause means it’s time up for a woman shouldn’t exist and is a ludicrous idea, according to her. She confirmed that in collaborating with Amyris, they’re looking to equip all the facets and intricacies of menopause with resources, tools, and products that help make the women going through that feel empowered and celebrated both emotionally and physically. She believes that no one should have to go through this journey alone. She said that she couldn’t be more proud and delighted to share with the world what they’ve been working on really soon.

Amyris’ President and Chief Executive Officer, John Melo, was happy to welcome Ms. Watts to the team. He said that they were glad to be joining her in her efforts to support women’s health and destigmatize menopause.

*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.

BUSINESS

Can B Corp (OTCMKTS: CANB) Secures Lease for 300,000 Square Foot Facility in McMinnville, Tennessee, and Decibel Expands into the Province of New Brunswick

Published

on

The health and wellness company focused on developing, production, and sales, Can B Corp (OTCMKTS: CANB) announced that it acquired a lease for 300,000 square feet on August 25. The cannabinoids company secured the lease to support the acquisition of assets recently closed from Music city Botanicals. Moreover, the company acquired the right of first refusal and purchased the facility outright during the lease period. 

Can B acquired facility is located between Nashville and Chattanooga in Tennessee, roughly 75 miles away from each city and police headquarters of Tennessee. The facility currently has two sub-tenants acquiring 20% of the hemp storage, hemp drying, and building. Also, it encompasses the R&D department, TN Botanicals’ owned isomer lab, and facilities. In addition, the facility is already loaded with a rail spur and has generators for backup at a one-megawatt capacity. 

Management Statement

Chief Executive Officer of Can B, Marco Alfonsi, stated that acquiring this 300,000 square foot facility which assists in operation is a massive win for their company. Furthermore, the facility’s location, existing infrastructure, and footprint will enhance its capabilities and enable Can B to become the leading producer of cannabinoids, hemp-based products in America. Additionally, the assets acquired by the Music City Botanicals recently within this facility will add additional expansion, extraction production with Delta-10, CBG, CBDA, CBN products. Additionally, new products of the company will include CBD grade in retails sectors. 

Decibel expands into the province of New Brunswick.

A leading producer of a premium cannabis company, Decibel, announced that it is expanding into the province of New Brunswick. The cannabis company expands its province after acquiring approval from Cannabis NB. Decibel expects its initial purchase order from Cannabis NB in September. Along with New Brunswick, the company’s adult-use premium cannabis are available in Alberta, British Columbia, Saskatchewan, Manitoba, and Prince Edward Island. 

*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.
Continue Reading

BUSINESS

Village Farms International Inc (NASDAQ: VFF) Announced Appointment of CFO for Balanced Health Botanicals and Sunniva Inc (OTCMKTS: SNNVF) Appoints Norman Valz to its Board of Directors

Published

on

Village Farms International Inc (NASDAQ: VFF) announced that Balanced Health Botanicals, a 100% owned subsidy, has appointed Alejandro (Alex) de Gortari as its Chief Financial Officer. De Gortari is regarded as consumer products and finance veteran. It is learned that de Gortari replaces Brandon Townsley, who has called it quits from Balanced Health, to pursue other professional interests. To his credit, the newly announced CFO has more than 15 years of experience with Molson Coors Brewing Co. De Gortari has held senior positions in the U.S. consumer products segment and cannabis industries. 

CEO Village Farms is happy to have Alex on the leadership team

President, and CEO of Balanced Health Botanicals, Chase Terwilliger, expressed that he is happy to have de Gortari as Chief Financial Officer, The President, and CEO, added that he is confident that the close to two decades of experience that de Gortari brings with him can help in scripting a new chapter in the growth of the group. Terwilliger added that de Gortari’s professional contributions could help Balanced Health expand its cannabinoid platform, paving the way for growth opportunities in the future. The President also wished the CFO good luck. 

Balanced Health Botanicals develops high-end CBD-based health and wellness products. The company has established a diverse product portfolio that includes cannabinoid products, CBD products ingestible, edible, and topical applications available online and in the physical channels. 

Sunniva Inc (OTCMKTS: SNNVF) Appoints Norman Valz to its Board of Directors

Sunniva Inc (OTCMKTS: SNNVF) recently announced that the company had appointed Norman Valz to its board of directors. The new appointment comes as a vacancy was created when Luke Stanton and Todd R. Patrick resigned in 2020. In addition, it is learned that Valz will be a part of the group’s board of directors till the next annual general meeting of shareholders is held. 

A law practitioner in Philidelphia and New York, Valz is an expert in commercial litigation, securities, corporate governance, and international business transactions. In his career spanning several decades, Valz has mentored start-ups for more than three decades. 

*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.
Continue Reading

BUSINESS

Acreage Holdings Inc (OTCMKTS: ACRHF) Appoints New Executive Vice President of Government Relations, and Dr. Sigal Tavor (MD) Joins Cannabics Pharmaceuticals Inc (OTCMKTS: CNBX) Board of Advisors

Published

on

Acreage Holdings Inc (OTCMKTS: ACRHF) has appointed Bryan Murray as Executive Vice President of Government Relations, it is learned. The appointment stands effective from August 23. 

CEO of the company looking forward to working with Murray

Meanwhile, Peter Caldini, Chief Executive Officer Acreage Holdings Inc, said that he is confident that Murray’s leadership skills can help build long-term collaborative relationships with government officials, regulators, and partners at the local, state, and national levels. The CEO believes it can go a long way in enhancing cannabis legislation. 

The group’s CEO went on record and stated that Murray has to his credit more than a decade of experience in the policy and regulatory sector while serving at Pfizer. Caldini added that he is confident that Murray can partner with essential policymakers to bring sustainable results. 

Dr. Sigal Tavor (MD) taken as Board of Advisors for Cannabics Pharmaceuticals Inc (OTCMKTS: CNBX)

Cannabics Pharmaceuticals Inc (OTCMKTS: CNBX) has taken Dr. Sigal Tavor (MD) as its board of advisors. The development comes after an announcement made by the company to have included to its board of advisors Prof. Caroline Robert (MD, Ph.D.), a Melanoma expert along with Prof. Amos Toren (MD), Prof. Zamir Halpern (MD), Dr. Erez Scapa (MD), Dr. Dana Ben-Ami Shor (MD), Dr. Sigalit Arieli-Portnoy (Ph.D.) and Dr. Tal Mofkadi (Ph.D.). Additionally, it is learned that the official announcement was made after the company announced that it had expanded its Board of Directors. It is known that Dr. Inbar Maymon-Pomeranchik (Ph.D.) and Dr. Gil Feiler (Ph.D.) have joined the group as Independent Directors. 

Dr. Tavor will work towards improving the drug discovery platform of the company

The appointment of Dr. Tavor as Board of Advisors is a part of the group’s initiative to enhance its drug discovery platform and research abilities. The company will focus on its ongoing cancer programs besides focusing on Hematology. A source from the group shared that it will not stop the production process of its new drug candidates for additional indications.

*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.
Continue Reading

Trending Stories